ArticleFrontiers in cell and developmental biology2026
Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma.
Jun Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.